EGFR activation promotes dimer PKM2 expression and nuclear translocation to activate HIF-1α, contributing to abnormal glycolysis and tumor cell proliferation (Yang et al., 2011; Yang et al., 2018; Wang et al., 2020). The gene discussed is HIF1A; the disease is neoplasm.